Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Crude Oil Sharply Lower; Vaccine Efficacy in Doubt

Published 30/11/2021, 14:34
Updated 30/11/2021, 14:34
© Reuters.

By Peter Nurse   

Investing.com -- Oil prices slumped Tuesday amid worries about the efficacy of the current vaccines to cope with the new Covid variant, raising fears of prolonged travel curbs and another hit to fuel demand.

By 9:15 AM ET (1415 GMT), U.S. crude futures traded 3.7% lower at $67.39 a barrel, while the Brent contract fell 3.9% to $70.35.

U.S. Gasoline RBOB Futures were down 2.8% at $2.9766 a gallon.

Sparking the latest selloff were comments from Moderna (NASDAQ:MRNA) CEO, Stephane Bancel, in a Financial Times interview, that existing vaccines would struggle to cope with the Omicron variant, predicting a "material drop" in their effectiveness.

Regeneron (NASDAQ:REGN) added to the concerns by releasing a statement on Tuesday indicating that analysis suggested its Covid-19 antibody cocktail could have reduced activity against the new variant.

A number of countries worldwide have already imposed travel curbs on travelers from southern Africa, where the Omicron variant was first discovered, and worries are mounting that these restrictions could last for a while if vaccines have to be reconfigured.

“It is still too early to sensibly assess the risk that omicron poses and this uncertainty is likely to add further volatility to the oil market,” said analysts at ING, in a note.

On the back of this weakening demand outlook, expectations are growing that the Organization of the Petroleum Exporting Countries and Russia, a group known as OPEC+, will decide to hold back on their previous plan to add 400,000 barrels a day to global supply in January, when it meets on Thursday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

“The group has already delayed its Joint Ministerial Monitoring Committee and Joint Technical Committee meeting to later in the week, in the hope that more information with regards to omicron would become available,” ING said. “We would not rule out the group pausing its supply increases over January.”

Also of interest to the crude market was the resumption of talks between Iran and world powers to try to save their 2015 nuclear deal, an agreement of which could result in the U.S. lifting sanctions on the Persian Gulf country.

“Lifting sanctions on Iran would see a sizable increase in Iranian supply. Iranian output is currently around 2.5MMbbls/d, whilst prior to the U.S. pulling out of the nuclear deal, Iran produced as much as 3.8MMbbls/d,” ING said.

U.S. inventory data from the American Petroleum Institute are due at 4:30 PM ET.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.